共 50 条
- [21] Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis Clinical Rheumatology, 2007, 26 : 1517 - 1521
- [25] Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis LANCET RHEUMATOLOGY, 2024, 6 (10): : e655 - e657
- [29] Plasma S-nitrosothiols in systemic sclerosis and Raynaud's phenomenon NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2012, 27 : S40 - S41
- [30] Controlled trial of tadalafil in Raynaud phenomenon (RP) secondary to systemic sclerosis (SSc). ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S523 - S523